Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for adults with focal epilepsy and blood-brain barrier effects
MOH_2019-05-08_004760Phase 3Not yet recruiting
- Sponsor
- ד"ר פליקס בנינגר
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of losartan in Focal Onset Epilepsy, sponsored by ד"ר פליקס בנינגר. Primary endpoint: Change in blood-brain barrier disruption. Planned start Dec 2018; status: not yet recruiting.
02
Drugs
losartan
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on MOH_2019-05-08_004760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-05-08_004760.